Ten things we learned about COVID-19

Maurizio Cecconi^{1

2}, Guido Forni³, Alberto Mantovani^{4

5

6}

Affiliations

¹ Humanitas Clinical and Research Center, via Manzoni 56, Rozzano, 20089, Milan, Italy. maurizio.cecconi@hunimed.eu.
² Humanitas University, via Rita Levi Montalcini, Pieve Emanuele, 20090, Milan, Italy. maurizio.cecconi@hunimed.eu.
³ Accademia Nazionale Dei Lincei, Rome, Italy.
⁴ Humanitas Clinical and Research Center, via Manzoni 56, Rozzano, 20089, Milan, Italy.
⁵ Humanitas University, via Rita Levi Montalcini, Pieve Emanuele, 20090, Milan, Italy.
⁶ The William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.

PMID: 32504103
PMCID: PMC7273118
DOI: 10.1007/s00134-020-06140-0

Ten things we learned about COVID-19

Maurizio Cecconi et al. Intensive Care Med. 2020 Aug.

. 2020 Aug;46(8):1590-1593.

doi: 10.1007/s00134-020-06140-0. Epub 2020 Jun 5.

Authors

Maurizio Cecconi^{1

2}, Guido Forni³, Alberto Mantovani^{4

5

6}

Affiliations

¹ Humanitas Clinical and Research Center, via Manzoni 56, Rozzano, 20089, Milan, Italy. maurizio.cecconi@hunimed.eu.
² Humanitas University, via Rita Levi Montalcini, Pieve Emanuele, 20090, Milan, Italy. maurizio.cecconi@hunimed.eu.
³ Accademia Nazionale Dei Lincei, Rome, Italy.
⁴ Humanitas Clinical and Research Center, via Manzoni 56, Rozzano, 20089, Milan, Italy.
⁵ Humanitas University, via Rita Levi Montalcini, Pieve Emanuele, 20090, Milan, Italy.
⁶ The William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.

PMID: 32504103
PMCID: PMC7273118
DOI: 10.1007/s00134-020-06140-0

No abstract available

PubMed Disclaimer

Conflict of interest statement

Alberto Mantovani acknowledges support by Dolce & Gabbana fashion company. Guido Forni and Maurizio Cecconi declare no conflict of interest for this paper.

Figures

**Fig. 1**
A schematic representation of the pathogenesis of COVID-19. *ACE2* angiotensin-converting enzyme 2, *TLR* toll-like receptors, Mϕ macrophages, DC dendritic cells, *IFN* interferon, *down arrow interferon* low IFN, *ARDS* acute respiratory distress syndrome, dots indicate more receptors involved (e.g. CD147 for viral entry)

See this image and copyright information in PMC

Cited by

Long Covid: where we stand and challenges ahead.
Mantovani A, Morrone MC, Patrono C, Santoro MG, Schiaffino S, Remuzzi G, Bussolati G; Covid-19 Commission of the Accademia Nazionale dei Lincei. Mantovani A, et al. Cell Death Differ. 2022 Oct;29(10):1891-1900. doi: 10.1038/s41418-022-01052-6. Epub 2022 Sep 7. Cell Death Differ. 2022. PMID: 36071155 Free PMC article. Review.
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19.
Brunetta E, Folci M, Bottazzi B, De Santis M, Gritti G, Protti A, Mapelli SN, Bonovas S, Piovani D, Leone R, My I, Zanon V, Spata G, Bacci M, Supino D, Carnevale S, Sironi M, Davoudian S, Peano C, Landi F, Di Marco F, Raimondi F, Gianatti A, Angelini C, Rambaldi A, Garlanda C, Ciccarelli M, Cecconi M, Mantovani A. Brunetta E, et al. Nat Immunol. 2021 Jan;22(1):19-24. doi: 10.1038/s41590-020-00832-x. Epub 2020 Nov 18. Nat Immunol. 2021. PMID: 33208929
Association of polymorphisms in long pentraxin 3 and its plasma levels with COVID-19 severity.
Feitosa TA, de Souza Sá MV, Pereira VC, de Andrade Cavalcante MK, Pereira VRA, da Costa Armstrong A, do Carmo RF. Feitosa TA, et al. Clin Exp Med. 2023 Aug;23(4):1225-1233. doi: 10.1007/s10238-022-00926-w. Epub 2022 Oct 31. Clin Exp Med. 2023. PMID: 36315310 Free PMC article.
Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Coperchini F, Chiovato L, Rotondi M. Coperchini F, et al. Front Immunol. 2021 Apr 26;12:668507. doi: 10.3389/fimmu.2021.668507. eCollection 2021. Front Immunol. 2021. PMID: 33981314 Free PMC article. Review.
Family support in intensive care units during COVID-19 visit ban: A multinational Delphi Study during first COVID-19 wave.
Jeitziner MM, Jenni-Moser B, Zante B, Erne K, Brauchle M, Moser SA, Schefold JC, Amrein K, Hoffmann M. Jeitziner MM, et al. Intensive Crit Care Nurs. 2023 Feb;74:103308. doi: 10.1016/j.iccn.2022.103308. Epub 2022 Aug 2. Intensive Crit Care Nurs. 2023. PMID: 35985909 Free PMC article.

See all "Cited by" articles

References

1. Tai W, et al. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol. 2020 doi: 10.1038/s41423-020-0400-4. - DOI - PMC - PubMed
1. Ferretti L, et al. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science. 2020 doi: 10.1126/science.abb6936. - DOI - PMC - PubMed
1. Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
1. Vabret N, et al. Immunology of COVID-19: current state of the science. Immunity. 2020 doi: 10.1016/j.immuni.2020.05.002. - DOI - PMC - PubMed
1. Sethuraman N, Jeremiah SS, Ryo A. Interpreting diagnostic tests for SARS-CoV-2. JAMA. 2020 doi: 10.1001/jama.2020.8259. - DOI - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Ten things we learned about COVID-19

Affiliations

Ten things we learned about COVID-19

Authors

Affiliations

Conflict of interest statement

Figures

Similar articles

Cited by

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources